These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8007520)

  • 21. [Evaluation of clinical efficacy of isoniazid and ethambutol in the treatment of nontuberculous mycobacteriosis based on in vitro susceptibility testing].
    Tsukamura M
    Kekkaku; 1989 Aug; 64(8):511-8. PubMed ID: 2811008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro activity of quinolones and macrolides against mycobacteria.
    Yew WW; Piddock LJ; Li MS; Lyon D; Chan CY; Cheng AF
    J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum.
    Barrett MS; Jones RN; Erwin ME; Koontz FP
    Diagn Microbiol Infect Dis; 1992 Feb; 15(2):169-71. PubMed ID: 1315233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and bacteriological study of sparfloxacin on bacterial prostatitis].
    Suzuki K; Horiba M; Naide Y; Shinoda M; Hibi H
    Hinyokika Kiyo; 1992 Jan; 38(1):121-8. PubMed ID: 1312292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chemotherapy of pulmonary Mycobacterium kansasii infection].
    Mizutani S
    Kekkaku; 1996 Sep; 71(9):527-31. PubMed ID: 8914388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of quinolones against mycobacteria.
    Jacobs MR
    Drugs; 1999; 58 Suppl 2():19-22. PubMed ID: 10553700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis.
    Lefèvre JC; Escaffre MC; Courdil M; Lareng MB
    Pathol Biol (Paris); 1993 Apr; 41(4):313-5. PubMed ID: 8233628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins.
    Saito H; Tomioka H; Sato K; Emori M; Yamane T; Yamashita K; Hosoe K; Hidaka T
    Antimicrob Agents Chemother; 1991 Mar; 35(3):542-7. PubMed ID: 2039206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal inhibitory concentrations of lomefloxacin and minocycline against drug-sensitive and drug-resistant isolates of M. tuberculosis compared on L-J and 7H11 media.
    Kamala T; Herbert D; Venkatesan P; Paramasivan CN
    Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):375-8. PubMed ID: 9401493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro susceptibility of Mycobacterium kansasii to the difluorinated quinolone sparfloxacin using a broth microdilution and macrodilution MIC system.
    Royo P; Martín-Casabona N; Martínez E; Andonegui M
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):349-53. PubMed ID: 10206507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria.
    Guillemin I; Jarlier V; Cambau E
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2084-8. PubMed ID: 9687411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria.
    Young LS; Berlin OG; Inderlied CB
    Am J Med; 1987 Apr; 82(4A):23-6. PubMed ID: 3107379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Reactivities of various mycobacteria species against DNA probes (Gen-Probe Rapid Diagnostic System) specific to Mycobacterium tuberculosis complex, Mycobacterium avium and Mycobacterium intracellulare].
    Tomioka H; Sato K; Saito H; Tasaka H
    Kekkaku; 1991 Jun; 66(6):405-11. PubMed ID: 1942722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies.
    Klopman G; Fercu D; Renau TE; Jacobs MR
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2637-43. PubMed ID: 8913479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of quinolones against mycobacteria.
    Jacobs MR
    Drugs; 1995; 49 Suppl 2():67-75. PubMed ID: 8549419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro evaluation of various quinolone antibacterial agents against veterinary mycoplasmas and porcine respiratory bacterial pathogens.
    Hannan PC; O'Hanlon PJ; Rogers NH
    Res Vet Sci; 1989 Mar; 46(2):202-11. PubMed ID: 2704885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to new macrolides, new quinolones, and antituberculous drugs on Dubos agar medium].
    Ogawa K; Miwa T; Sasamoto M; Sasaki T; Tsuda M; Honda K; Furui H; Torii K; Takagi K
    Kekkaku; 1992 Nov; 67(11):735-8. PubMed ID: 1487866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
    Foroumadi A; Soltani F; Moshafi MH
    Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of the minimal effective dosages of ofloxacin and sparfloxacin against M. leprae in the mouse foot pad system.
    Traore I; Ji B; Lienhardt C; Bobin P; Grosset J
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):142-5. PubMed ID: 8690973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.